45 results
8-K
EX-99.2
RCEL
AVITA Medical Inc
10 Jan 24
AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update
4:05pm
, enhancing the integration of PermeaDerm into our portfolio. This strategic collaboration underscores our commitment to delivering innovative solutions
8-K
EX-10.1
hpyrs3e50ck4x36nqac
18 Oct 23
Preliminary commercial revenue of $13.5 million for the third quarter 2023; full year 2023 guidance confirmed
9:07am
8-K
EX-10.2
pr957rm90 dz
18 Oct 23
Preliminary commercial revenue of $13.5 million for the third quarter 2023; full year 2023 guidance confirmed
9:07am
8-K
3g8zzf1
18 Oct 23
Preliminary commercial revenue of $13.5 million for the third quarter 2023; full year 2023 guidance confirmed
9:07am
424B5
20n3jp
18 Oct 23
Prospectus supplement for primary offering
9:04am
8-K
EX-99.2
oo07lqfmpk ixo4vey
12 May 23
AVITA Medical Reports First Quarter Financial Results and Affirms Full Year Guidance
4:01pm
424B2
ryahnn1
25 Apr 23
Prospectus for primary offering
5:28pm
8-K
EX-99.1
9hy5z4y
30 Sep 22
AVITA Medical Appoints Industry Leader James Corbett as Chief Executive Officer
8:54am
10-KT
EX-10.29
hfuwbgszvt sc
28 Feb 22
Annual report (with FYE transition)
4:11pm
10-KT
w1ln1oh6x
28 Feb 22
Annual report (with FYE transition)
4:11pm
8-K
EX-99.1
2lada91k4ezdbr
11 Jan 22
Results of Operations and Financial Condition
4:02pm
8-K
EX-10.2
e05g uymce
4 Jun 21
Avita Medical, Inc. Appoints Two New Non-executive Members to
6:03am
8-K
EX-10.1
2jm0fm
4 Jun 21
Avita Medical, Inc. Appoints Two New Non-executive Members to
6:03am